Episodes 106-120 of 120
Is Managing Gout in the Nephrology Clinic a Challenge?
MinuteCE®Is Managing Gout in the Nephrology Clinic a Challenge?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®Center of the Target: Which Patients Are Most Likely to Develop Gout?
Treat or Refer: Who Is Responsible for Managing Gout?
MinuteCE®Treat or Refer: Who Is Responsible for Managing Gout?
Can You Manage Patients With Uncontrolled Gout More Effectively?
MinuteCE®Can You Manage Patients With Uncontrolled Gout More Effectively?
What’s New About Gout? Rheumatology Perspective
MinuteCE®What’s New About Gout? Rheumatology Perspective
- advertisement
What Are the Emerging Therapies for Managing Gout?
MinuteCE®What Are the Emerging Therapies for Managing Gout?
Should We Look for Gout in the Cardiology Clinic?
MinuteCE®Should We Look for Gout in the Cardiology Clinic?
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
CME/CEImproving Symptoms in Patients with HFrEF Using Novel Device Therapy
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
CME/CETackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
CME/CEClosing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
CME/CEDirect from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
- advertisement
Heart Failure Grand Rounds: 3 Things You Need to Know About Cardiac Contractility Modulation
CME/CEHeart Failure Grand Rounds: 3 Things You Need to Know About Cardiac Contractility Modulation
Experts Discuss Longevity and Durability with TAVR
CME/CEExperts Discuss Longevity and Durability with TAVR
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
Global Heart Failure AcademyCARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
